Abstract:Objective To investigate the values of plasma CTGF, iPTH, thyroid hormones,NT-proBNP, and LVMI in elderly patients with chronic heart failure and their correlations with cardiac function. Methods A total of 120 cases of elderly patients with chronic heart failure treated in our hospital between June 2016 and December 2017 were selected as the case group, whose plasma CTGF, iPTH, thyroid hormones, NT-proBNP and LVMI were detected.According to the NYHA cardiac function classification standard, these patients were divided into grade Ⅱ, Ⅲ,and Ⅳ groups, with 40 cases in each. Another 40 healthy elderly patients treated in the same period were selected as the control group.The levels of plasma CTGF, iPTH, thyroid hormones,NT-proBNP and LVMI were compared between the four groups. Spearman correlation was used to analyze the correlations between plasma CTGF, iPTH, thyroid hormones, NT-proBNP, LVMI and cardiac function grading in patients with chronic heart failure. Results ①The levels of plasma CTGF, iPTH, NT-proBNP and LVMI in grade Ⅱ, Ⅲ and Ⅳ groups were significantly higher than those in the control group (P<0.01). These levels increased with the grade. The difference was statistically significant (P<0.05).②The level of FT3 in grade Ⅱ, Ⅲ and Ⅳ groups was significantly lower than that in the control group (P<0.01),which decreased with the grade, and the difference was statistically significant (P<0.05).③The results of Spearman correlation analysis indicated that there was a positive correlation between plasma CTGF, iPTH, NT-proBNP,LVMI and cardiac function grading (ρ>0.6,P<0.05). FT3 was negatively correlated with cardiac function grading (ρ>-0.6,P<0.05).④ The results of Pearson correlation analysis showed that plasma CTGF, iPTH,NT-proBNP and LVMI were positively correlated (r>0.6,P<0.05). FT3 was negatively correlated with LVMI (r<-0.6,P<0.05). Conclusions Plasma CTGF, iPTH, FT3, NT-proBNP and LVMI are strongly correlated with cardiac function grading in elderly patients with chronic heart failure, which can be used as important indicators for clinical diagnosis and condition evaluation of chronic heart failure.
Christian F B,Velduisen D J V,Ven L L,et al.Influence of order and type of drug (bisoprolol vs enalapril) on outcome and adverse events in patients with chronic heart failure:a post hoc analysis of the CIBIS-Ⅲ trial [J].Eur J Heart Failure,2011,13(7):765-772.
The Cardiovascular Diseases Society of Chinese Medical Association.Editorial Office of Chinese Journal of Cardiology.2014 Guideline for the Management of Heart Failure China[J].Chin J Cardio,2014,42(2):98-122.
El-Menyar A,Sulaiman K,Almahmeed W,et al.Serum troponin in patients presenting with acute heart failure and high BNP/NT-proBNP without electrocardiographic evidence of ST-Elevation myocardial infarction[J].Circ J,2016,134:A18067.
[12]
Luchner A,Von H S,Holubarsch C,et al.Indications and clinical implications of the use of the cardiac markers BNP and NT-proBNP[J].Dtsch Med Wochenschr,2017,142( 5):346.
Shatynskamytsyk I,Rodrigo L,Cioccocioppo R,et al. The impact of thyroid hormone replacement therapy on left ventricular diastolic function in patients with subclinical hypothyroidism [J]. J Endocrinol Invest,2016,39(6):709-713.
[15]
Eng J,McClelland R L,Gomes A S,et al. Adverse left ventricular remodeling and age assessed with cardiac MR imaging:the multi-ethnic study of atherosclerosis[J].Radiology,2016,278(3):714-722.